Measuring Upper Airway Cross Sectional Areas During Residual Neuromuscular Blockade and After Reserval

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorTamas Vegh, MD

About this trial

In our study, the investigators sought to answer the question of how the retroglossal pharyngeal areas measured after extubation of patients compare to baseline (before muscle relaxation) values. The investigators also investigated how these areas change as a function of TOF ratios measured at extubation, thus looking for a correlation between residual muscle relaxant effect and airway area.

Eligibility criteria

Qualifiers

ASA 1-3;

BMI 18.5-25 (normal body weight);

men/women in equal proportion;

duration of surgeries at least ≥ 30 minutes;

Disqualifiers

drugs affecting neuromuscular function (magnesium, aminoglycosides);

difficult airway, expected difficult intubation;

pregnancy (pregnancy test for women of childbearing age to rule out pregnancy we finish);

breastfeeding;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Tamas Vegh, MD

Lead sponsor

University of Debrecen

Sponsor institution